Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TreeSummarizedExperiment: a S4 class for data with hierarchical structure. | F1000Res | 2020 | 33274053 | PubTator, text mining | PubMed |
| Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. | Mol Cell | 2020 | 33259812 | PubTator, text mining | PubMed |
| Chronic Treatment with a Phytosomal Preparation Containing Centella asiatica L. and Curcuma longa L. Affects Local Protein Synthesis by Modulating the BDNF-mTOR-S6 Pathway. | Biomedicines | 2020 | 33256214 | PubTator, text mining | PubMed |
| Pan-RAF Inhibition Shows Anti-Leukemic Activity in RAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells with FLT3 Mutation. | Cancers (Basel) | 2020 | 33255818 | PubTator, text mining | PubMed |
| Single-cell peripheral immunoprofiling of Alzheimer's and Parkinson's diseases. | Sci Adv | 2020 | 33239300 | PubTator, text mining | PubMed |
Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response. | J Hematol Oncol | 2020 | 33239060 | PubTator, text mining | PubMed |
| CD147 Expressed on Memory CD4+ T Cells Limits Th17 Responses in Patients With Rheumatoid Arthritis. | Front Immunol | 2020 | 33193313 | PubTator, text mining | PubMed |
| Implementing Curcumin in Translational Oncology Research. | Molecules | 2020 | 33182817 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction contributes to Rapamycin-induced apoptosis of Human Glioblastoma Cells - A synergistic effect with Temozolomide. | Int J Med Sci | 2020 | 33162811 | PubTator, text mining | PubMed |
| Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines. | Cancer Cell | 2020 | 33157050 | PubTator, text mining | PubMed |
| Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity. | Mol Cell | 2020 | 33157014 | PubTator, text mining | PubMed |
| Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer. | Breast Cancer Res | 2020 | 33138866 | PubTator, text mining | PubMed |
| The Oncometabolite 5'-Deoxy-5'-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation. | Front Immunol | 2020 | 33123121 | PubTator, text mining | PubMed |
| Biomarkers for Inflammatory Breast Cancer: Diagnostic and Therapeutic Utility. | Breast Cancer (Dove Med Press) | 2020 | 33116817 | PubTator, text mining | PubMed |
| WDR5 Promotes Proliferation and Correlates with Poor Prognosis in Oesophageal Squamous Cell Carcinoma. | Onco Targets Ther | 2020 | 33116631 | PubTator, text mining | PubMed |
| A new species concept for the clinically relevant Mucor circinelloides complex. | Persoonia | 2020 | 33116336 | PubTator, text mining | PubMed |
| Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells. | Cell Syst | 2020 | 33113355 | PubTator, text mining | PubMed |
| Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet? | Cancers (Basel) | 2020 | 33105560 | PubTator, text mining | PubMed |
| Metabolic defects in splenic B cell compartments from patients with liver cirrhosis. | Cell Death Dis | 2020 | 33099582 | PubTator, text mining | PubMed |
| Novel genomic targets of valosin-containing protein in protecting pathological cardiac hypertrophy. | Sci Rep | 2020 | 33093614 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=40